Which statement about transitioning from IV insulin to subcutaneous insulin is correct?

Prepare for the ABFAS Boards - Rearfoot and Forefoot exam. Enhance your skills with flashcards and multiple-choice questions complete with hints and explanations. Excel in your certification journey!

Multiple Choice

Which statement about transitioning from IV insulin to subcutaneous insulin is correct?

Explanation:
Transitioning from IV to subcutaneous insulin should happen when the patient can resume eating, with a brief overlap to maintain continuous insulin coverage. If the patient can take oral intake, shifting to a subcutaneous regimen 1–2 hours after this point provides meal coverage with rapid-acting insulin while the IV infusion is tapered off. This overlap prevents a gap in insulin delivery and supports both basal needs and post-meal glucose control. Delaying the switch to 48 hours or insisting on staying on IV insulin postoperatively risks unnecessary continued IV therapy and poor matching of insulin delivery to meals or recovery, while not switching at all misses the opportunity for standard glucose management as the patient resumes eating.

Transitioning from IV to subcutaneous insulin should happen when the patient can resume eating, with a brief overlap to maintain continuous insulin coverage. If the patient can take oral intake, shifting to a subcutaneous regimen 1–2 hours after this point provides meal coverage with rapid-acting insulin while the IV infusion is tapered off. This overlap prevents a gap in insulin delivery and supports both basal needs and post-meal glucose control. Delaying the switch to 48 hours or insisting on staying on IV insulin postoperatively risks unnecessary continued IV therapy and poor matching of insulin delivery to meals or recovery, while not switching at all misses the opportunity for standard glucose management as the patient resumes eating.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy